West Pharmaceutical Services (WST) insider buying

Healthcare · Medical Instruments & Supplies · Market cap $26.0B

12 open-market purchases of WST by West Pharmaceutical Services's executives and directors since December 2023, worth $0 in total, from SEC Form 4 filings.

The most recent: Ro Khanna bought — on January 29, 2026.

The biggest buyer over the period is Ro Khanna: 6 purchases, $0.

By year

YearPurchasesValue
20262$0
20258$0
20232$0

Biggest buyers

InsiderBuysValue
Ro Khanna
6$0
Lisa C. Mcclain
2$0
Robert Bresnahan, Jr.
2$0
Jared Moskowitz
2$0

Every purchase

Newest first. From SEC Form 4 filings. Insider buying across the market.

DateInsiderSharesPriceValueFiling
Jan 29, 2026 Ro Khanna
0$232.20— —
Jan 29, 2026 Ro Khanna
0$232.20— —
Jun 17, 2025 Lisa C. Mcclain
0$218.18— —
Jun 17, 2025 Lisa C. Mcclain
0$218.18— —
May 19, 2025 Ro Khanna
0$217.00— —
May 19, 2025 Ro Khanna
0$217.00— —
Apr 23, 2025 Ro Khanna
0$217.48— —
Apr 23, 2025 Ro Khanna
0$217.48— —
Feb 25, 2025 Robert Bresnahan, Jr.
0$220.34— —
Feb 25, 2025 Robert Bresnahan, Jr.
0$220.34— —
Dec 28, 2023 Jared Moskowitz
0$354.93— —
Dec 28, 2023 Jared Moskowitz
0$354.93— —
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for WST.
Open WST in Investingly

Questions

Are West Pharmaceutical Services insiders buying the stock?

12 open-market purchases of WST by West Pharmaceutical Services's executives and directors since December 2023, worth $0 in total, from SEC Form 4 filings. The most recent: Ro Khanna bought — on January 29, 2026.

What counts as insider buying here?

Open-market purchases (Form 4 code P) by officers and directors. Option exercises, grants and purchases by 10% owners are left out.

From West Pharmaceutical Services's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.